Functional validation of the SMOC1 matrisomal protein network in Alzheimers disease
SMOC1 基质体蛋白网络在阿尔茨海默病中的功能验证
基本信息
- 批准号:10571158
- 负责人:
- 金额:$ 10.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdultAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloid beta-42Amyloid beta-ProteinArchitectureAutopsyBehaviorBiological ProcessBiologyBrainCalcium BindingCellsCentral Nervous SystemClinicalCo-ImmunoprecipitationsCognitionComputer softwareDataDevelopmentDevelopment PlansDiseaseDisease ProgressionDrosophila genusDrosophila melanogasterDrug TargetingEnvironmentEthicsExperimental ModelsExtracellular MatrixExtracellular Matrix ProteinsFunctional disorderFundingGeneticGoalsGrantHistologyHomeostasisHomologous ProteinHumanImmunoprecipitationIndividualInstitutionInternationalInvestigationLeadershipLinkMaintenanceMass Spectrum AnalysisMediatingMedicineMentorsMentorshipModelingNerve DegenerationNeurogliaNeurologyNeuronsNeurosciencesPathogenesisPathologicPathologyPathway AnalysisPathway interactionsProteinsProteomicsPublishingRNA InterferenceReporterResearchResearch PersonnelResearch TrainingRoleScientistSeriesSignal PathwaySignal TransductionStructureSystems BiologyTauopathiesTechnologyTherapeuticTrainingTransforming Growth Factor betaValidationWNT Signaling PathwayWorkWritingbeta cateninbrain tissuecareercareer developmentcell typeclinically relevantcollegedata integrationdesigndifferential expressiondrug developmentexperienceexperimental studyfightingflyimprovedin vivoknock-downlaboratory experiencelarge scale datalink proteinmeetingsmembermutantneuronal cell bodyneuropathologyneurophysiologynovelnovel markerpre-clinicalprogramsprotein expressionprotein functionprotein protein interactionskill acquisitionskillssymposiumtau Proteinstherapeutic targettraittranslational approachtranslational potentialtranslational scientist
项目摘要
Project Summary/Abstract
This proposal describes a five-year mentored laboratory training experience designed to lead to an independent
academic research career dissecting the underlying biology of Alzheimer’s disease (AD). The applicant’s career
goal is to become a prominent scientist in the AD research filed by leading an independently funded research
group. The career development plan includes training designed to broaden the applicant’s scientific skillset by:
(1) employing translational approaches to identify and characterize key proteins of an AD-associated network to
determine how they contribute to AD pathogenesis, (2) utilizing systems biology approaches to dissect network
behavior when key interconnected proteins are perturbed and (3) using cross-species approaches to identify
additional proteins linked to specific AD pathological triggers as therapeutic targets in the fight against AD. This
plan incorporates additional training in leadership, mentorship, grant-writing, and ethics. During the period of
mentored research training, the applicant will engage in skills acquisition, didactic training, seminars,
international conferences, and meetings with his mentor and mentorship committee, followed by a transition to
independence. The proposed research aims to improve our understanding of the biology underlying AD
progression through investigation of an AD-associated protein network. We have identified the human M42
network that is strongly correlated with pathology and declining cognition in AD. Based on network analyses,
SPARC Related Modular Calcium Binding-1 (SMOC1) was identified as a potential network driver that best
represents the behavior of the entire network. The overall project goal is to validate and elucidate the role of
M42 by dissecting SMOC1 function in the Drosophila model. My cross-species approach will powerfully enhance
our understanding of SMOC1 in the adult brain, which is predicted to modulate both TGFβ and wnt/β-catenin
signaling pathways, and identify additional M42 proteins important in AD pathology, thus informing a therapeutic
rationale for further studies in mammalian preclinical AD models. This five year project will take place primarily
at Baylor College of Medicine, an institution with nationally recognized research programs in genetics,
neuroscience and AD. The Department of Neurology has an outstanding track record of training early stage
investigators to become successful translational researchers. The research environment provides the best
intellectual environment, cutting edge technologies and state-of-the art facilities. The proposal provides a broad
research experience in systems biology analysis of proteomic data, cross-species validation of a translationally
relevant protein network, along with functional characterization of its proposed driver protein SMOC1, a novel
biomarker and potential therapeutic target in AD. Completion of this proposal and its associated training plan
will prepare this applicant to become an independent scientist and leader in the AD research field.
项目摘要/摘要
该建议描述了五年的实验室培训经验,旨在导致独立
学术研究职业剖析了阿尔茨海默氏病的基本生物学(AD)。申请人的职业
目标是成为领导一项独立资助的研究提交的广告研究中的杰出科学家
团体。职业发展计划包括旨在扩大申请人科学技能的培训:
(1)采用翻译方法来识别和表征与广告相关网络的关键蛋白
确定它们如何促进AD发病机理,(2)利用系统生物学方法剖析网络
当关键互连蛋白受到干扰时的行为,并且(3)使用跨物种方法识别
与特定的AD病理触发因素作为与AD斗争的治疗靶标相关的其他蛋白质。这
计划将领导力,精通授权和道德的额外培训纳入。期间
指导的研究培训,申请人将从事技能掌握,教学培训,半手,
国际会议,并与他的心理和心态委员会会面,然后过渡到
独立。拟议的研究旨在提高我们对生物学基础广告生物学的理解
通过研究AD相关蛋白网络的进展。我们已经确定了人类M42
与病理学密切相关的网络和AD认知的下降。基于网络分析,
与SPARC相关的模块化钙结合1(SMOC1)被确定为最好的网络驱动器
代表整个网络的行为。总体项目目标是验证和阐明
M42通过在果蝇模型中解剖SMOC1功能。我的跨物种方法将有力增强
我们对成人大脑中SMOC1的理解,该大脑预计将同时调节TGFβ和Wnt/β-catenin
信号通路,并确定在AD病理学中重要的其他M42蛋白质,从而告知治疗性
哺乳动物临床前广告模型的进一步研究的理由。这个五年项目将举行
在贝勒医学学院(Baylor Medicine),该机构拥有全国认可的遗传学研究计划,
神经科学和广告。神经病学系有培训早期的出色记录
研究人员成为成功翻译的研究人员。研究环境提供了最好的
智力环境,尖端技术和最先进的设施。该提案提供了广泛的
蛋白质组学数据的系统生物学分析,跨物种验证的研究经验
相关的蛋白质网络,以及其提出的驱动器蛋白SMOC1的功能表征,这是一种新颖的
AD中的生物标志物和潜在的治疗靶标。该建议及其相关培训计划的完成
将准备该申请人成为广告研究领域的独立科学家和领导者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Edward Li-Kroeger其他文献
David Edward Li-Kroeger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 10.29万 - 项目类别:
The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
- 批准号:
10678125 - 财政年份:2023
- 资助金额:
$ 10.29万 - 项目类别:
Developing a nonpharmacological pain intervention for community dwelling older adults with dementia
为社区居住的痴呆症老年人开发非药物疼痛干预措施
- 批准号:
10644490 - 财政年份:2023
- 资助金额:
$ 10.29万 - 项目类别:
DNA methylation signatures of Alzheimer's disease in aged astrocytes
老年星形胶质细胞中阿尔茨海默病的 DNA 甲基化特征
- 批准号:
10807864 - 财政年份:2023
- 资助金额:
$ 10.29万 - 项目类别: